comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists It's important to study the difference in medications. Our analysis found is associated a lower risk of serious heart complications compared to dulaglutide in adults with Type Cardiovascular, mortality, and kidney outcomes

If a GLP-1 is prescribed for another eligible medical condition, it will be covered according to the Part D plans rules

Long-term safety remains largely unknown due to limited research and regulation

Peter Attia, MDa longevity and wellness expert and host of the The Drive podcast discusses this in detail in his blog post, Lean mass loss on GLP-1 receptor agonists: a downside of the miracle drugs. He discusses how Ozempic causes both muscle and fat loss and does not improve body composition as much as natural weight loss methods

It was linked to the ability of the BPC 157 to balance the vasodilative process in the arteries

It is also known for its powerful antioxidant properties, which help neutralise free radicals and support skin health

Disclosure provided under FTC 16 CFR Part 255